Dutta Debjani, Barr Valarie A, Akpan Itoro, Mittelstadt Paul R, Singha Laishram I, Samelson Lawrence E, Ashwell Jonathan D
Laboratory of Immune Cell Biology, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland, USA.
Laboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Nat Immunol. 2017 Feb;18(2):196-204. doi: 10.1038/ni.3640. Epub 2016 Dec 12.
Calcineurin is a phosphatase whose primary targets in T cells are NFAT transcription factors, and inhibition of calcineurin activity by treatment with cyclosporin A (CsA) or FK506 is a cornerstone of immunosuppressive therapies. Here we found that calcineurin was recruited to the T cell antigen receptor (TCR) signaling complex, where it reversed inhibitory phosphorylation of the tyrosine kinase Lck on Ser59 (Lck). Loss of calcineurin activity impaired phosphorylation of Tyr493 of the tyrosine kinase ZAP-70 (ZAP-70), as well as some downstream pathways in a manner consistent with signaling in cells expressing Lck (Lck that cannot be phosphorylated) or Lck (a phosphomimetic mutant). Notably, CsA inhibited integrin-LFA-1-dependent and NFAT-independent adhesion of T cells to the intercellular adhesion molecule ICAM-1, with little effect on cells expressing mutant Lck. These results provide new understanding of how widely used immunosuppressive drugs interfere with essential processes in the immune response.
钙调神经磷酸酶是一种磷酸酶,其在T细胞中的主要作用靶点是NFAT转录因子,用环孢素A(CsA)或FK506处理抑制钙调神经磷酸酶活性是免疫抑制疗法的基石。在此,我们发现钙调神经磷酸酶被招募至T细胞抗原受体(TCR)信号复合物,在该复合物中它使酪氨酸激酶Lck的Ser59位点(Lck)的抑制性磷酸化发生逆转。钙调神经磷酸酶活性丧失会损害酪氨酸激酶ZAP-70(ZAP-70)的Tyr493位点的磷酸化,以及一些下游信号通路,其方式与在表达Lck(无法被磷酸化的Lck)或Lck(一种模拟磷酸化的突变体)的细胞中的信号传导一致。值得注意的是,CsA抑制T细胞依赖整合素-LFA-1且不依赖NFAT的与细胞间黏附分子ICAM-1的黏附,对表达突变型Lck的细胞影响很小。这些结果为广泛使用的免疫抑制药物如何干扰免疫反应中的关键过程提供了新的认识。